Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn

NCT01789723 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Non Hodgkin's Lymphoma

Interventions

DRUG: Fusilev
DRUG: Folotyn

Sponsor

Acrotech Biopharma Inc.